Back to Search
Start Over
LATEST COMPANY NEWS
- Source :
- United Kingdom Pharmaceuticals. October 22, 2024
- Publication Year :
- 2024
-
Abstract
- PMLiVE - Roche's Alecensa receives NICE recommendation to treat ALK-positive lung cancer - 21/10/2024 Roche's Alecensa (alectinib) has been recommended by the National Institute of Health and Care Excellence (NICE) [...]
- Subjects :
- GSK PLC
Pfizer Inc.
Roche Holding (UK) Ltd.
Seagen Inc.
AstraZeneca PLC
Sanofi S.A.
United States. Food and Drug Administration
Association of the British Pharmaceutical Industry
European Union
Alecensa (Medication)
Enhertu (Medication)
Verzenio (Medication)
Mounjaro (Medication)
Yervoy (Medication)
Paxlovid (Medication)
Opdivo (Medication)
Breyanzi (Medication)
Lung cancer
Nuclear industry
Cancer prevention
Biotechnology industries
Pharmaceutical industry
Lymphomas
Nuclear energy
Alectinib
Biotechnology industry
Cancer -- Prevention
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- United Kingdom Pharmaceuticals
- Publication Type :
- News
- Accession number :
- edsgcl.813316656